Registration Strip Icon for default Register for Free to get streaming real-time quotes, interactive charts, live options flow, and more.

SNSS

Sunesis Pharmaceuticals (SNSS)

Sunesis Pharmaceuticals Inc
Date:
Sort by:
 Showing the most relevant articles for your search:NASDAQ:SNSS
DateTimeSourceHeadlineSymbolCompany
11/05/20184:05PMGlobeNewswire Inc.Sunesis Pharmaceuticals Reports Third Quarter 2018 Financial Results and Recent HighlightsNASDAQ:SNSSSunesis Pharmaceuticals Inc
11/01/20189:17AMGlobeNewswire Inc.Sunesis Pharmaceuticals Announces Presentations at 60th American Society of Hematology Annual MeetingNASDAQ:SNSSSunesis Pharmaceuticals Inc
10/29/20187:00AMGlobeNewswire Inc.Sunesis Pharmaceuticals to Host Conference Call on November 5th to Discuss Third Quarter 2018 Financial Results and Recent Hi...NASDAQ:SNSSSunesis Pharmaceuticals Inc
09/26/20187:00AMGlobeNewswire Inc.Sunesis Pharmaceuticals to Present at the 2018 Cantor Global Healthcare ConferenceNASDAQ:SNSSSunesis Pharmaceuticals Inc
08/30/20187:00AMGlobeNewswire Inc.Sunesis Pharmaceuticals to Present at the Wells Fargo Securities 2018 Healthcare ConferenceNASDAQ:SNSSSunesis Pharmaceuticals Inc
08/08/20186:14AMEdgar (US Regulatory)Quarterly Report (10-q)NASDAQ:SNSSSunesis Pharmaceuticals Inc
08/07/20184:54PMEdgar (US Regulatory)Current Report Filing (8-k)NASDAQ:SNSSSunesis Pharmaceuticals Inc
08/07/20184:05PMGlobeNewswire Inc.Sunesis Pharmaceuticals Reports Second Quarter 2018 Financial Results and Recent HighlightsNASDAQ:SNSSSunesis Pharmaceuticals Inc
07/31/20187:00AMGlobeNewswire Inc.Sunesis Pharmaceuticals to Host Conference Call on August 7th to Discuss Second Quarter 2018 Financial Results and Recent Hig...NASDAQ:SNSSSunesis Pharmaceuticals Inc
07/10/20184:32PMEdgar (US Regulatory)Amended Statement of Ownership (sc 13g/a)NASDAQ:SNSSSunesis Pharmaceuticals Inc
07/09/20187:00AMGlobeNewswire Inc.Sunesis Pharmaceuticals Strengthens Senior Management TeamNASDAQ:SNSSSunesis Pharmaceuticals Inc
07/03/20187:53PMEdgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:SNSSSunesis Pharmaceuticals Inc
07/03/20187:49PMEdgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:SNSSSunesis Pharmaceuticals Inc
07/03/20187:40PMEdgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:SNSSSunesis Pharmaceuticals Inc
07/03/20187:35PMEdgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:SNSSSunesis Pharmaceuticals Inc
07/03/20187:32PMEdgar (US Regulatory)Initial Statement of Beneficial Ownership (3)NASDAQ:SNSSSunesis Pharmaceuticals Inc
06/26/20185:05PMEdgar (US Regulatory)Current Report Filing (8-k)NASDAQ:SNSSSunesis Pharmaceuticals Inc
06/25/20184:10PMEdgar (US Regulatory)Current Report Filing (8-k)NASDAQ:SNSSSunesis Pharmaceuticals Inc
06/25/20184:10PMGlobeNewswire Inc.Sunesis Pharmaceuticals Enters into $15.5 Million Common Stock Purchase Agreement with Aspire Capital Fund, LLCNASDAQ:SNSSSunesis Pharmaceuticals Inc
06/25/20184:09PMEdgar (US Regulatory)Prospectus Filed Pursuant to Rule 424(b)(5) (424b5)NASDAQ:SNSSSunesis Pharmaceuticals Inc
06/18/20187:00AMGlobeNewswire Inc.Sunesis Pharmaceuticals Announces Presentations at the EHA Annual MeetingNASDAQ:SNSSSunesis Pharmaceuticals Inc
06/07/20186:07AMEdgar (US Regulatory)Current Report Filing (8-k)NASDAQ:SNSSSunesis Pharmaceuticals Inc
05/08/20184:54PMEdgar (US Regulatory)Quarterly Report (10-q)NASDAQ:SNSSSunesis Pharmaceuticals Inc
05/08/20184:46PMEdgar (US Regulatory)Current Report Filing (8-k)NASDAQ:SNSSSunesis Pharmaceuticals Inc
05/08/20184:00PMGlobeNewswire Inc.Sunesis Pharmaceuticals Reports First Quarter 2018 Financial Results and Recent HighlightsNASDAQ:SNSSSunesis Pharmaceuticals Inc
05/01/20184:05PMGlobeNewswire Inc.Sunesis Pharmaceuticals to Host Conference Call on May 8th to Discuss First Quarter 2018 Financial Results and Recent Highlig...NASDAQ:SNSSSunesis Pharmaceuticals Inc
04/25/20181:39PMEdgar (US Regulatory)Additional Proxy Soliciting Materials (definitive) (defa14a)NASDAQ:SNSSSunesis Pharmaceuticals Inc
04/25/20181:21PMEdgar (US Regulatory)Proxy Statement (definitive) (def 14a)NASDAQ:SNSSSunesis Pharmaceuticals Inc
04/12/20185:08PMEdgar (US Regulatory)Proxy Statement - Notice of Shareholders Meeting (preliminary) (pre 14a)NASDAQ:SNSSSunesis Pharmaceuticals Inc
03/14/20184:05PMGlobeNewswire Inc.Sunesis Pharmaceuticals to Present at Upcoming Investor ConferencesNASDAQ:SNSSSunesis Pharmaceuticals Inc
 Showing the most relevant articles for your search:NASDAQ:SNSS